NCT03086707View on ClinicalTrials.gov

Prefatory Study to Explore Changes in Nasal Mucociliary Clearance and to Standardize Nasal Scraping Procedure

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 21, 2017

Primary Completion Date

August 14, 2017

Study Completion Date

September 29, 2017

Conditions
SmokersNever Smokers
Interventions
OTHER

Cigarette

After enrollment, and between Visit 2 and Visit 3, the subjects will abstain from smoking for a period of 8 hours. At Visit 3, after the 8-hour smoking abstinence period, the subjects will smoke 1 single cigarette.

Trial Locations (2)

07753

Inflamax Research - Neptune, Neptune City

07105

Inflamax Research - Newark, Newark

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY

NCT03086707 - Prefatory Study to Explore Changes in Nasal Mucociliary Clearance and to Standardize Nasal Scraping Procedure | Biotech Hunter | Biotech Hunter